Watchlist Price Alert

Adamis Pharmaceuticals Co... (ADMP)

NASDAQ: ADMP · Real-Time Price · USD

0.78

0.01 (1.50%)

At close: Sep 07, 2023, 7:59 PM

Adamis Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-26.48M	-45.83M	-49.39M	-29.31M	-39.01M	-25.54M	-19.44M
Depreciation & Amortization	1.48M	1.44M	3.61M	2.94M	3.1M	3.06M	2.53M
Stock-Based Compensation	-340.27K	1.98M	4.42M	5.87M	6.54M	6.06M	4.76M
Other Working Capital	-4.22M	-11.9M	8.53M	-470.54K	-1.99M	870.95K	-984.65K
Other Non-Cash Items	775.36K	6.21M	843.67K	18.46K	3.63M	1.14M	-2.75M
Deferred Income Tax	n/a	9.21M	14.49M	1.21M	-372.47K	-343.55K	-4.59M
Change in Working Capital	-1.34M	-10.8M	5.13M	-616.42K	-6.54M	487.98K	-3.05M
Operating Cash Flow	-25.9M	-37.79M	-20.9M	-19.89M	-32.66M	-15.13M	-21.16M
Capital Expenditures	-680.42K	-1.22M	-946.21K	-2.87M	-3.54M	-2.09M	-121.1K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	381.88K
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	4.16M	1.51M	n/a	n/a	n/a	-24.74K	-32
Investing Cash Flow	3.48M	282.74K	-946.21K	-2.87M	-3.54M	-2.09M	260.75K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	285M	53.94M	19.89M	12.29M	37.13M	30.46M	21.91M
Financial Cash Flow	285K	53.94M	19.89M	12.29M	37.13M	30.46M	21.91M
Net Cash Flow	-22.14M	16.5M	-1.96M	-10.46M	938.94K	13.24M	1.02M
Free Cash Flow	-26.58M	-39.01M	-21.85M	-22.75M	-36.19M	-17.22M	-21.28M